Definitive Healthcare Corp. DH
1.19 USD +0.07 (+6.25%)
At closeNov 10, 2026, 6:57 PM EST
1.22 +0.03 +2.34%
After hours · Nov 10, 6:57 PM ET
1.09 Day range 1.20
0.628 52-week range 2.87
- YTD
- -58.54%
- 1 year
- -58.25%
News
globenewswire.com Definitive Healthcare Reports Financial Results for Third Quarter 2026 FRAMINGHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics,…
globenewswire.com Definitive Healthcare announces executive appointments to bolster AI-powered initiatives across the company Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer
defenseworld.net Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison Definitive Healthcare (NASDAQ: DH - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will…
globenewswire.com Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety Alongside other industry leaders, Definitive Healthcare demonstrates…
defenseworld.net Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH) HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednesday's regular session. The company's market cap stands at $3.9 million. Gelteq (NASDAQ:GELS) shares…
globenewswire.com Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an…
benzinga.com Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey…
globenewswire.com Definitive Healthcare Appoints Clay Ritchey as CEO FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced…
defenseworld.net Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the…
defenseworld.net Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduce" from the nine analysts that are covering the firm, Marketbeat.com reports. Three equities…
benzinga.com Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5 Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and lowers the price target from $2.5 to $1.5.
seekingalpha.com Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
zacks.com Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.
marketbeat.com Definitive Healthcare Q2 Earnings Call Highlights Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
benzinga.com Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est Definitive Healthcare (NASDAQ:DH) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 analyst estimate. Narrows FY2026 sales outlook from $220.000 million-$226.000 million to…- benzinga.com Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.04-$0.05 vs $0.04 analyst estimate. sees sales of $54.000 million-$55.000 million vs $55.542 million analyst estimate.
benzinga.com Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 28.57 percent decrease over earnings of…
globenewswire.com Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions Unifying claims, provider, consumer, and expert…
globenewswire.com Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced…
zacks.com Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
globenewswire.com Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring…- benzinga.com B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7 B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Underperform and lowers the price target from $3.5 to $0.7.
prnewswire.com Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success Customer success leader joins executive team to help restaurant operators accelerate value realization, adoption, and business outcomes. IRVINE, Calif.
globenewswire.com Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights FRAMINGHAM, Mass. , May 21, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a provider of healthcare data and analytics, today announced several product enhancements designed to give…
seekingalpha.com Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript- benzinga.com Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1 Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $2.75 to $1.
benzinga.com Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term performance. Latest list of oversold players with RSI below 30: GOSS (26.3), BWAY (19.1), DH (20.2).
benzinga.com Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $3 Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and lowers the price target from $4 to $3.
benzinga.com Stephens & Co. Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $2 Stephens & Co. analyst Jeff Garro maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and lowers the price target from $3 to $2.
benzinga.com Definitive Healthcare Q4 Earnings Report: What Investors Need to Know - benzinga.com Definitive Healthcare Sees FY2026 Adj EPS $0.14-$0.17 vs $0.26 Est; Sees Sales $220.000M-$226.000M vs $234.138M Est Definitive Healthcare (NASDAQ:DH) is looking for FY2026 Adj EPS of $0.14-$0.17 vs $0.26 analyst estimate. sees sales of $220.000 million-$226.000 million vs $234.138 million analyst estimate.
- benzinga.com Definitive Healthcare Sees Q1 Adj EPS $0.03 vs $0.06 Est; Sees Sales $54.000M-$56.000M vs $57.228M Est Definitive Healthcare (NASDAQ:DH) is looking for Q1 Adj EPS of $0.03 vs $0.06 analyst estimate. sees sales of $54.000 million-$56.000 million vs $57.228 million analyst estimate.
benzinga.com Definitive Healthcare Q4 Adj. EPS $0.06, Inline, Sales $61.534M Beat $59.569M Estimate Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 25 percent decrease over earnings of $0.08 per share from the same…
benzinga.com Earnings Scheduled For February 26, 2026 - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75 Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $3 to $2.75.- benzinga.com Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $4 Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and lowers the price target from $5 to $4.
- benzinga.com Definitive Healthcare Raises FY2025 Adj EPS Guidance from $0.22-$0.23 to $0.23-$0.24 vs $0.23 Est; Raises FY2025 Sales Guidance from $237.000M-$240.000M to $239.000M-$240.000M vs $238.424M Est Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.22-$0.23 to $0.23-$0.24 vs $0.23 analyst estimate. Raises FY2025 sales outlook from $237.000 million-$240.000 million to…
- benzinga.com Definitive Healthcare Sees Q4 Adj EPS $0.05-$0.06 vs $0.06 Est; Sees Sales $59.000M-$60.000M vs $59.148M Est Definitive Healthcare (NASDAQ:DH) is looking for Q4 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 million-$60.000 million vs $59.148 million analyst estimate.
- benzinga.com Definitive Healthcare Q3 Adj. EPS $0.07 Beats $0.06 Estimate, Sales $60.046M Beat $59.488M Estimate Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.06 by 27.27 percent. This is a 30 percent decrease over earnings of…
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com Stifel Maintains Buy on Definitive Healthcare, Raises Price Target to $6 Stifel analyst David Grossman maintains Definitive Healthcare (NASDAQ:DH) with a Buy and raises the price target from $5 to $6.
- benzinga.com Definitive Healthcare Raises FY2025 Adj EPS Guidance from $0.20-$0.23 to $0.22-$0.23 vs $0.21 Est; Raises FY2025 Sales Guidance from $234.000M-$240.000M to $237.000M-$240.000M vs $237.041M Est Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.20-$0.23 to $0.22-$0.23 vs $0.21 analyst estimate. Raises FY2025 sales outlook from $234.000 million-$240.000 million to…
- benzinga.com Definitive Healthcare Sees Q3 Adj EPS $0.05-$0.06 vs $0.06 Est; Sees Sales $59.000M-$60.000M vs $59.215M Est Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 million-$60.000 million vs $59.215 million analyst estimate.
- benzinga.com Definitive Healthcare Q2 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $60.750M Beat $59.200M Estimate Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 22.22 percent decrease over earnings of…
- benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session